The Safety and Efficacy of DCA for the Treatment of Brain Cancer

This study has been completed.
Sponsor:
Collaborator:
Capital Health, Canada
Information provided by (Responsible Party):
University of Alberta
ClinicalTrials.gov Identifier:
NCT00540176
First received: October 4, 2007
Last updated: October 10, 2014
Last verified: February 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2009
  Primary Completion Date: August 2009 (Final data collection date for primary outcome measure)